根据该协议,Cytokinetics将获得5000万美元用于商业上市,并在该药获得FDA批准用于治疗阻塞性肥厚性心肌病(oHCM)的12个月内...查看全文
chuminhua05-14 16:42
5/13,,Cytokinetics $Cytokinetics(CYTK)$ 公布了其在研心肌病药物 aficamten 的一项关键 III 期试验的详细结果,表明该药物可帮助患者显著提高运动能力,并且在许多功能和症状指标上也优于安慰剂。
研发主管 Fady Malik 表示,SEQUOIA-HCM 试验结果“强烈支持 aficamten 的潜在批准,我们期...查看全文
Cytokinetics(CYTK)04-09 04:45
$Cytokinetics(CYTK)$ ARS Annual Report to Security Holders Accession Number: 0001140361-24-018629 Act: 34 Size: 10 MB 网页链接查看全文
Cytokinetics(CYTK)05-17 06:25
$Cytokinetics(CYTK)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-24-015725 Size: 6 KB 网页链接查看全文
Cytokinetics(CYTK)05-17 06:05
$Cytokinetics(CYTK)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-24-015719 Size: 6 KB 网页链接查看全文
Cytokinetics(CYTK)05-08 19:15
$Cytokinetics(CYTK)$ 8-K Current report, item 8.01 Accession Number: 0000950170-24-055054 Act: 34 Size: 161 KB 网页链接查看全文
Cytokinetics(CYTK)05-23 05:05
$Cytokinetics(CYTK)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001193125-24-145038 Act: 33 Size: 684 KB 网页链接查看全文
Cytokinetics(CYTK)06-04 04:05
$Cytokinetics(CYTK)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001193125-24-153006 Act: 33 Size: 65 KB 网页链接查看全文
Cytokinetics(CYTK)06-12 04:25
$Cytokinetics(CYTK)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-24-018365 Size: 9 KB 网页链接查看全文
Cytokinetics(CYTK)06-11 04:25
$Cytokinetics(CYTK)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-24-018246 Size: 4 KB 网页链接查看全文
财富6882013-09-04 13:35
,制药公司Cytokinetics股价$Cytokinetics(CYTK)$ 大幅下跌逾23%,主要由于该公司宣布用于治疗心脏疾病的药物omecamtiv mecarbil的测试表现未能达到缓解病人呼吸短促情况的预期目标。
当日,截至美国东部时间12:52(北京时间4日0:52)为止,Cytokinetics股价在纳斯达克市场的常规交易中下跌2...查看全文
Tanthius2013-04-22 08:13
这周持续关注的Lisrt:$奥特控股(ADAT)$ ,$Biocryst医药(BCRX)$ ,$Cytokinetics(CYTK)$ ,$Descartes Systems Group(DSCO)$ ,$乔斯牛仔裤(JOEZ)$ ,$Velti plc(VELT)$ ,$Athersys(ATHX)$ ,$ECOTALITY INC(ECTY)$ ,$奇景光电(HIMX)$ ,$阿库拉制药(ACUR)$ ,$OCZ(OCZ)$ ,$Affymax(AFFY)$ ,$艾菲矩阵(AFF...查看全文
来源:格隆汇 Cytokinetics(CYTK.US)暴涨65%,报75.42美元。消息上,该公司于当地时间12月27日宣布,SEQUOIA-HCM试验取得积极结果,这是针对其药物Aficamten在症状性阻塞性肥厚性心肌病(HCM)患者中的关键3... 网页链接
智通财经APP获悉,Cytokinetics(CYTK.US)表示,其正在研发的心脏病药物在一项受到密切关注的试验中帮助了患有遗传性心脏疾病的患者,这引发了有关该公司可能被收购的传言。消息公布后,该股盘前涨超50%,报69美元。 Cytokinetics在一... 网页链接
$Cytokinetics(CYTK)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-24-018859 Size: 7 KB 网页链接
$Cytokinetics(CYTK)$ 144 Report of proposed sale of securities Accession Number: 0001950047-24-004854 Act: 33 Size: 6 KB 网页链接
$Cytokinetics(CYTK)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-24-018855 Size: 7 KB 网页链接
$Cytokinetics(CYTK)$ 144 Report of proposed sale of securities Accession Number: 0001950047-24-004797 Act: 33 Size: 5 KB 网页链接
$Cytokinetics(CYTK)$ 144 Report of proposed sale of securities Accession Number: 0001950047-24-004637 Act: 33 Size: 8 KB 网页链接
$Cytokinetics(CYTK)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-24-018365 Size: 9 KB 网页链接
$Cytokinetics(CYTK)$ 144 Report of proposed sale of securities Accession Number: 0001950047-24-004578 Act: 33 Size: 4 KB 网页链接
$Cytokinetics(CYTK)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-24-018246 Size: 4 KB 网页链接
$Cytokinetics(CYTK)$ 8-K Current report, item 8.01 Accession Number: 0001193125-24-157531 Act: 34 Size: 139 KB 网页链接
$Cytokinetics(CYTK)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-24-018143 Size: 6 KB 网页链接